Xencor (XNCR) Interest Coverage Ratio (2013 - 2026)
Xencor (XNCR) reported Interest Coverage Ratio of 16.57 for Q1 2026, down 232.42% year-over-year from 12.51 in Q1 2025, and down 127.17% quarter-over-quarter from 7.29 in Q4 2025.
Xencor (XNCR) Interest Coverage Ratio (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 10 years of Interest Coverage Ratio data on file, last reported at 16.57 in Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 16.57, down 232.42% year-over-year; the trailing twelve-month figure through Mar 2026 was 7.59 (down 61.98% YoY), and the FY2025 annual result was 5.56, down 14.19% from the prior year.
- Interest Coverage Ratio declined to 16.57 in Q1 2026 per XNCR's latest filing, from 7.29 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 1.52 in Q4 2024 and troughed at 8677.71 in Q1 2023.
- A 4-year average of 1158.79 and a median of 6.12 in 2024 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio soared 99.93% in 2024, then plunged 379.17% in 2025.
- A 4-year view of Interest Coverage Ratio shows it stood at 4.44 in 2023, then soared by 65.75% to 1.52 in 2024, then sank by 379.17% to 7.29 in 2025, then slumped by 127.17% to 16.57 in 2026.
- Business Quant data shows XNCR's Interest Coverage Ratio at 16.57 in Q1 2026, 7.29 in Q4 2025, and 6.2 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - | -16.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.57 |
| Dec 31, 2025 | -7.29 |
| Sep 30, 2025 | -6.20 |
| Jun 30, 2025 | -4.02 |
| Mar 31, 2025 | -4.98 |
| Dec 31, 2024 | -1.52 |
| Sep 30, 2024 | -6.12 |
| Jun 30, 2024 | -5.97 |
| Mar 31, 2024 | -5.65 |
| Dec 31, 2023 | -4.44 |
| Sep 30, 2023 | -2,610.00 |
| Jun 30, 2023 | -3,713.86 |
| Mar 31, 2023 | -8,677.71 |
| Jun 30, 2018 | -9,430.00 |
| Mar 31, 2018 | -7,662.25 |
| Dec 31, 2017 | 1,065.20 |
| Sep 30, 2017 | -7,860.00 |
| Jun 30, 2017 | -2,836.67 |
| Mar 31, 2017 | -5,453.00 |
| Dec 31, 2016 | 557.11 |